| 000 | 00786 a2200241 4500 | ||
|---|---|---|---|
| 005 | 20250515084931.0 | ||
| 264 | 0 | _c20070927 | |
| 008 | 200709s 0 0 eng d | ||
| 022 | _a0193-7758 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHausman, Daniel M | |
| 245 | 0 | 0 |
_aThird-party risks in research: should IRBs address them? _h[electronic resource] |
| 260 |
_bIRB _c |
||
| 300 |
_a1-5 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 |
_aClinical Trials as Topic _xadverse effects |
| 650 | 0 | 4 |
_aEthics Committees, Research _xstandards |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aResearch Subjects |
| 650 | 0 | 4 | _aRisk Assessment |
| 650 | 0 | 4 |
_aThird-Party Consent _xethics |
| 773 | 0 |
_tIRB _gvol. 29 _gno. 3 _gp. 1-5 |
|
| 999 |
_c17375457 _d17375457 |
||